BioNano Genomics Inc vs Snap Inc — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Snap Inc trades at $5.49 (market cap $9.32B). The key difference: Snap Inc is far larger — about 682.3× BioNano Genomics Inc's market cap, and Snap Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | SNAP | |
|---|---|---|
Market Cap | $13.66M | $9.32B |
Sector | Health | Media |
52-Week High | $4.92 | $9.09 |
52-Week Low | $1.06 | $3.93 |
Enterprise Value | $16.26M | $10.88B |
Trailing returns across standard periods
Latest headlines on both assets
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →